Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Company News
Events
Directory
Search
Close search
Home
Company
Intertek
Intertek
Activities:
Regulatory
Cleaning
Nutraceutical
X
LinkedIn
Trending Articles
Dairy trends: IFF report identifies factors driving industry expansion
The IFF report highlights five trends that are currently driving market changes, including health labelling, consistent quality and sustainability credentials
Activating autophagy: a nutritional strategy with longevity applications
As consumers prioritise their healthspan as opposed to their lifespan, the targeted use of dietary spermidine to stimulate autophagy is emerging as a promising healthy ageing...
ADM’s gut health probiotic approved by the Chinese NHC
DE111, ADM’s proprietary spore-forming probiotic, has been certified by the National Health Commission in China
dsm-firmenich and Lallemand partner to launch early life synbiotic solutions
The solution will contain a combination of human milk oligosaccharides (HMOs) that will mimic breast milk, boosting the infant immune system and gut microbiome
The perfect pair: how vitamins K2 and D3 combine to support health and well-being
Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet...
Upcoming event
Vitafoods Europe
14–16 May 2024 | Exhibition | Palexpo, Geneva
See all
Related Content
Ingredients
Chinova enlists Intertek to prepare for GRAS ruling on mushroom fibre ingredient
Chinova Bioworks has received a No Questions Letter from the US FDA for its Chiber Mushroom Fiber, a natural food and beverage preservative
Skin Care
Intertek Clinical Research Services moves to new laboratory facility
Intertek Clinical Research Services has more than doubled the size of its laboratory, enabling it to accommodate and deliver larger projects for its customers
Regulatory
Testing conditions for Intertek as 2013 results move steadily forward
Growth of revenues of £2,184m (up 6.3%) and profits £343m (up 2.2%) masked some tough conditions in the chemicals and pharma division.
Subscribe now